Affordable Access

deepdyve-link
Publisher Website

Women Authors in Nuclear Medicine Journals: a Survey from 2014 to 2020.

Authors
  • Lasnon, Charline1
  • Girault, Gilles2
  • Lebtahi, Rachida3
  • Ansquer, Catherine4
  • Lequesne, Justine5
  • Quak, Elske1
  • 1 UNICANCER, Comprehensive Cancer Center F. Baclesse, Nuclear Medicine Department, France. , (France)
  • 2 UNICANCER, Comprehensive Cancer Center F. Baclesse, Medical Library, France. , (France)
  • 3 Department of Nuclear Medicine, Beaujon Hospital, France. , (France)
  • 4 Department of Nuclear Medicine, University Hospital of Nantes, France. , (France)
  • 5 UNICANCER, Comprehensive Cancer Center F. Baclesse, Biostatistics Department Caen, France. , (France)
Type
Published Article
Publication Date
Oct 21, 2021
Identifiers
DOI: 10.2967/jnumed.121.262773
PMID: 34675110
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Despite the feminization of the medical workforce, women do not have the same career perspectives as men. In nuclear medicine, little information is available on the gender gap regarding prominent author positions of scientific articles. Therefore, the purpose of this study was to evaluate recent trends in the gender distribution of first and last authorship of articles published in nuclear medicine journals. Methods: We conducted a bibliometric analysis of first and last author gender of articles published from 2014 to 2020 in 15 nuclear medicine journals. Manuscript title, article type, journal impact factor, date of publication, first and last name and country of provenance of first and last authors were noted. The Gender-API software was used to determine author gender. All statistics were descriptive. Results: Women represented 32.8% of first authors and 19.6% of last ones. Female authorship increased from 28.2% (428 of 1518 articles) in 2014 to 35.5% (735 of 2069 articles, relative increase 72%) in 2020 (p<0.001) for first authors and from 15.6% (237 of 1518 articles) in 2014 to 20.5% (424 of 2069 articles, relative increase 79%) in 2020 (p<0.001) for last ones. Parity was forecasted in 2035 for first authors and in 2052 for last ones. Female authorship increased in Europe for first (P = 0.014) and last authors (p<0.001), in high-ranking journals for first (P = 0.004) and last authors (p<0.001) and in other journal ranks for last authors (P = 0.01). Female first and last authorship rose for original articles (P = 0.02 and P = 0.01 respectively) and case reports (p<0.001 and P = 0.002 respectively). Regarding collaborations, the proportion of articles produced by male first and last authors decreased from 62.2% in 2014 to 52.9% in 2020 in favor of female first and last authors (OR=1.07, p<0.001), male first and female last authors (OR =1.05, p<0.001) and female first and male last authors (OR=1.03, p<0.001). Conclusion: Female first and last authorship in nuclear medicine journals increased substantially from 2014 to 2020, in particular in high-ranking journals, in Europe and for original articles and case reports. Male/male collaborations decreased by 10% in favor of all other collaborations. Parity can be foreseen in a few decades. Copyright © 2021 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Report this publication

Statistics

Seen <100 times